Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00281944 · ClinicalTrials.gov registry record · Phase 1
Combination Chemotherapy in Treating Young Patients With Advanced Solid Tumors
A Phase 1 study, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- Phase 1
- Development phase
- 42
- Enrollment target
NCT00281944: Completed Phase 1 study, sponsored by National Cancer Institute (NCI).
NCT00281944 is a Phase 1 study that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 42 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00281944, a Phase 1 study, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 42 participants
- Enrollment target
Study Summary
This phase I trial is studying the side effects and best dose of oxaliplatin when given together with leucovorin and fluorouracil in treating young patients with advanced solid tumors. Drugs used in chemotherapy, such as oxaliplatin, leucovorin, and fluorouracil, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells.
Interventions
- DRUG oxaliplatin
- DRUG fluorouracil
- OTHER pharmacological study
- PROCEDURE positron emission tomography
- DRUG leucovorin calcium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2005-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00281944
The ClinicalTrials.gov registry entry for NCT00281944 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which oxaliplatin is the first listed.
NCT00281944 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00281944 about?
NCT00281944 is a clinical study titled "Combination Chemotherapy in Treating Young Patients With Advanced Solid Tumors". This phase I trial is studying the side effects and best dose of oxaliplatin when given together with leucovorin and fluorouracil in treating young patients with advanced solid tumors. Drugs used in chemotherapy, such as oxaliplatin, leucovorin, and fluorouracil, work in different ways to stop the g...
What is the current status of trial NCT00281944?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 42 participants. The study started on 2005-09.
What interventions are being tested in trial NCT00281944?
The interventions under investigation include: oxaliplatin (DRUG), fluorouracil (DRUG), pharmacological study (OTHER), positron emission tomography (PROCEDURE), leucovorin calcium (DRUG).
Who is sponsoring clinical trial NCT00281944?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.